Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis

P Galanis, I Vraka, D Fragkou, A Bilali… - Journal of Hospital …, 2021 - Elsevier
Summary Background Healthcare workers (HCWs) represent a high-risk population for
infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Aim To …

[HTML][HTML] Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review

CC Lai, JH Wang, PR Hsueh - International Journal of Infectious Diseases, 2020 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing the coronavirus
disease 2019 (COVID-19), has led to a global pandemic. However, the majority of currently …

Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy

G Apolone, E Montomoli, A Manenti, M Boeri… - Tumori …, 2021 - journals.sagepub.com
There are no robust data on the real onset of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infection and spread in the prepandemic period worldwide. We …

Seroprevalence of and risk factors associated with SARS-CoV-2 infection in health care workers during the early COVID-19 pandemic in Italy

P Poletti, M Tirani, D Cereda, G Guzzetta… - JAMA network …, 2021 - jamanetwork.com
Importance Identifying health care settings and professionals at increased risk of SARS-CoV-
2 infection is crucial to defining appropriate strategies, resource allocation, and protocols to …

Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and …

A Hossain, SM Nasrullah, Z Tasnim, MK Hasan… - …, 2021 - thelancet.com
Background Knowing the seroprevalence of SARS-CoV-2 IgG antibodies across geographic
regions before vaccine administration is one key piece of knowledge to achieve herd …

Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection

C Manisty, TA Treibel, M Jensen, A Semper, G Joy… - …, 2021 - thelancet.com
Background SARS-CoV-2 serology is used to identify prior infection at individual and at
population level. Extended longitudinal studies with multi-timepoint sampling to evaluate …

High seroprevalence but short‐lived immune response to SARS‐CoV‐2 infection in Paris

F Anna, S Goyard, AI Lalanne, F Nevo… - European journal of …, 2021 - Wiley Online Library
Although the COVID‐19 pandemic peaked in March/April 2020 in France, the prevalence of
infection is barely known. Using high‐throughput methods, we assessed herein the …

The seroprevalence of SARS-CoV-2 during the first wave in Europe 2020: A systematic review

NM Vaselli, D Hungerford, B Shenton, A Khashkhusha… - PloS one, 2021 - journals.plos.org
Background A year following the onset of the COVID-19 pandemic, new infections and
deaths continue to increase in Europe. Serological studies, through providing evidence of …

Prevalence of antibodies to SARS-CoV-2 following natural infection and vaccination in Irish hospital healthcare workers: changing epidemiology as the pandemic …

N Allen, M Brady, U Ni Riain, N Conlon… - Frontiers in …, 2022 - frontiersin.org
Background In October 2020 SARS-CoV-2 seroprevalence among hospital healthcare
workers (HCW) of two Irish hospitals was 15 and 4. 1%, respectively. We compare …

Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay

C Irsara, AE Egger, W Prokop, M Nairz… - Clinical Chemistry and …, 2021 - degruyter.com
Objectives Serological tests detect antibodies against Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) in the ongoing coronavirus disease-19 (COVID-19) pandemic …